CBT-1™ Overview

CBT-1™ demonstrates the ability to reverse multi-drug resistance to chemotherapy in cancer cells. CBT-1's™ ability to reverse multi-drug resistance in cancer cells enables the chemotherapy to effectively treat cancer without having demonstrated any significant side effects.

CBT-1™, taken orally as a pill, was developed to reverse multi-drug resistance in cancer cells and to become part of a Cancer Treatment Program that is administered before a cancer cell can become drug resistant.

Fourteen (14) plus years of research and development has shown that the use of CBT-1™ with reduced levels of chemotherapy can result in:

Clinical Trials Protocols
Patient Documentation regard the Phase III Non-Small Cell Lung Cancer Clinical Trials for CBT-1™ are now available.

MDR Demonstration

Drug resistance pump inside a cancer cell (Above). Click to see a Flash animation of CBT-1 in action! (77k)